Regulated Information - Global

Regulated Information

Filter

Period

Filter by

recent search

Reset

Showing: 1 – 05 of 125 Regulated Information

Correction: Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome  
Press Release Icon  –  21 July 2023

21 July 2023

Download
Correction: Ipsen provides update on E.U. Marketing Authorization Application for Bylvay® for cholestatic pruritus in patients with Alagille syndrome  

PARIS, FRANCE, 21 July 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of Bylvay® (odevixibat) for the…



Ipsen – Half year statement – 2023 06 30
Press Release Icon  –  10 July 2023

10 July 2023

Download
Ipsen – Half year statement – 2023 06 30

Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF


Combined Shareholders’ Meeting of 31 May 2023
Press Release Icon  –  21 April 2023

21 April 2023

Download
Combined Shareholders’ Meeting of 31 May 2023

Please download the associated documents for more information.


Voting rights on 31 March 2023
Press Release Icon  –  11 April 2023

11 April 2023

Download
Voting rights on 31 March 2023

This article or press release has no online content. Please download the associated documents for more information.


1 … 11 12 13 14 15 16 17 … 25
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.